News and Press - JDRF T1D Fund

i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman

October 12, 2021

SQZ Biotechnologies Announces First Autoimmune Disease Indication for Tolerizing Antigen Carrier (TAC) Platform

September 13, 2021 | WATERTOWN, MA

Inversago Pharma Initiates a Phase 1 Clinical Trial on INV-202, a Next Generation Peripherally-acting CB1 Blocker

September 07, 2021 | MONTREAL

GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation

August 11, 2021 | BOSTON, MA

Seraxis appoints Shelley Hartman, Jerry Baty and MJ Choi to the Board of Directors

August 10, 2021 | FREDERICK, MD